deltatrials
Recruiting OBSERVATIONAL NCT05885724

Novel Targetable BIOmarkers in ANorexia NervosA (BIOANNA)

Novel Targetable BIOmarkers in ANorexia NervosA - BIOANNA

Sponsor: University Hospital, Basel, Switzerland

Updated 5 times since 2023 Last updated: Dec 6, 2024 Started: May 1, 2023 Primary completion: Apr 30, 2025 Completion: Apr 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Anorexia Nervosa and Anorexia Nervosa Restricting Type and is currently actively recruiting participants. University Hospital, Basel, Switzerland leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2023 – ~Dec 2023 · 5 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – present · 18 months · monthly snapshotRecruiting

Change History

5 versions recorded
  1. Jan 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Jan 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Dec 2023 — Jul 2024 [monthly]

    Recruiting

  5. Jul 2023 — Dec 2023 [monthly]

    Recruiting

    First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Hospital, Basel, Switzerland
  • University of Zurich
Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations